MG
LLY icon

Marex Group’s Eli Lilly LLY Stock Holding History

Marex Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299M Buy
249,397
+103,723
+71% +$106M 1.27% 19
2026
Q1 		$134M Buy
145,674
+111,003
+320% +$113M 0.85% 31
2025
Q4 		$37.3M Sell
34,671
-338,743
-91% -$324M 0.23% 93
2025
Q3 		$285M Buy
373,414
+89,007
+31% +$66.2M 2.01% 14
2025
Q2 		$222M Buy
284,407
+83,306
+41% +$64.7M 1.92% 9
2025
Q1 		$166M Sell
201,101
-22,634
-10% -$18.8M 3.18% 7
2024
Q4 		$173M Buy
223,735
+75,508
+51% +$62.5M 2.94% 10
2024
Q3 		$131M Sell
148,227
-10,250
-6% -$9.22M 3% 9
2024
Q2 		$143M Buy
158,477
+4,035
+3% +$3.23M 3.85% 6
2024
Q1 		$120M Buy
154,442
+106,352
+221% +$75.7M 3.9% 4
2023
Q4 		$28M Buy
48,090
+47,331
+6,236% +$27.6M 1.1% 15
2023
Q3 		$408K Buy
759
+283
+59% +$146K 0.06% 129
2023
Q2 		$223K Buy
+476
New +$200K 0.04% 191
2023
Q1 		– Sell
-600
Closed -$220K – 296
2022
Q4 		$220K Buy
+600
New +$213K 0.03% 227

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marex Group's LLY Position: Q2 2026 in Review

Marex Group increased its Eli Lilly (LLY) stake by 71% in Q2 2026, buying an estimated $106M and bringing the position to 249,397 shares worth $299M. The position accounts for 1.27% of the portfolio, ranked #19.

Marex Group first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Marex Group held 249,397 shares of Eli Lilly worth $299M as of Q2 2026.
  • Marex Group bought 103,723 Eli Lilly shares in Q2 2026, an estimated $106M.
  • Eli Lilly made up 1.27% of Marex Group's portfolio in Q2 2026, its #19 holding.
  • Marex Group first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.